MHPAEA Parity Appeals for Solo Therapists: A Practical Guide

What's still in force — and what isn't

Mental health parity law in the United States is built in three layers. Understanding which layer is still being enforced matters because your appeal needs to cite the right one.

Layer 1 — The MHPAEA statute (2008). Still in force. The Mental Health Parity and Addiction Equity Act itself is federal law and has not been amended or repealed. It requires that financial requirements and treatment limitations applied to mental health and substance use disorder benefits be no more restrictive than those applied to medical/surgical benefits.

Layer 2 — The 2013 implementing regulations (29 CFR § 2590.712). Still in force. These are the rules that translated the 2008 statute into specific testing requirements for plans. They define quantitative treatment limitations (visit limits, day limits, dollar caps) and non-quantitative treatment limitations (medical necessity criteria, prior authorization rules, network composition). When a plan applies an NQTL more restrictively to mental health than to medical/surgical care, that's a parity violation under the 2013 rules.

Layer 3 — The CAA 2021 statutory NQTL comparative-analysis disclosure duty. Critically still in force. The Consolidated Appropriations Act of 2021, § 203, added a statutory requirement that plans produce a written comparative analysis of any NQTL applied to mental health benefits — on request — and make it available to participants, beneficiaries, and regulators. Because this duty is in the statute itself (not in a regulation), it cannot be paused by executive action.

Layer 4 — The 2024 Final Rule. Under federal non-enforcement since May 2025 following the ERIC v. DOL litigation and a tri-agency (DOL/HHS/Treasury) joint statement. The pause applies to the 2024 Rule's new concepts: the “meaningful benefits” standard, the “material differences in access” test, outcomes-data parity testing, and fiduciary certification requirements. Do not cite these provisions in a 2026 appeal — the plan can correctly point out they aren't being enforced.

Layer 5 — State parity laws. Unaffected by the federal pause. California, New York, Massachusetts, Illinois, and Oregon all have parity statutes that are stronger than federal MHPAEA and that apply to fully-insured plans regulated by the state. (Self-funded ERISA plans are federally preempted from most state law.)

The CAA 2021 § 203 hook: your unkillable demand

If you take one thing away from this guide, take this: the CAA 2021 § 203 written NQTL comparative-analysis demand is the strongest single tool you have. Three reasons.

It's statutory. It lives in the U.S. Code, not in a regulation that the executive branch can pause. The May 2025 non-enforcement statement explicitly covers only the 2024 Final Rule's new provisions. The CAA 2021 disclosure duty is older, separate, and uninterrupted.

It shifts the burden of proof to the plan. Most denial letters say things like “not medically necessary” or “prior authorization required.” The therapist is left guessing whether the plan applies the same standard to medical/surgical care. The comparative-analysis demand forces the plan to put their methodology in writing, with citations to their own medical policies, the data they used, and the conclusions they drew. Most plans cannot produce a defensible analysis. When they fail to produce one — or produce something that obviously ignores comparable medical/surgical care — that failure is itself evidence of a parity violation.

It travels with the appeal. If the plan ignores your first request, you have a specific, documented violation to bring to the state Department of Insurance, the DOL's EBSA, or (for ERISA plans) the external IRO review process. The disclosure failure becomes its own cause of action.

Sample demand language

Paste this paragraph into the appeal letter, adapted to the specific denial:

Under § 203 of the Consolidated Appropriations Act of 2021, codified at 29 U.S.C. § 1185a(a)(8), this plan is required to perform and produce a written comparative analysis of the non-quantitative treatment limitation applied to the above claim. I am requesting that written comparative analysis, including all factors evaluated and the methodology used to assess parity with comparable medical/surgical benefits. Please respond within 30 days. Failure to produce a defensible comparative analysis is itself evidence of a parity violation and will be escalated to the relevant state and federal regulators.

Send by certified mail or via the plan's appeal portal with a tracking number. Document the date.

Five denial codes that carry the parity argument

These five CARC codes are the most common ways behavioral health claims get denied in patterns that suggest a parity violation. Each one is a candidate for the CAA 2021 NQTL demand above.

CO-50 — Not Medically Necessary

The plan is saying the service wasn't medically necessary by their internal criteria. In behavioral health, “not medically necessary” is the single most common way plans deny ongoing therapy. The parity question is whether the plan's medical necessity criteria for mental health treatment are more restrictive than the criteria they apply to analogous outpatient medical/surgical care. Demand both sets of criteria in writing. If the plan can't produce parity, that's your case.

CO-119 — Benefit Maximum Reached

The patient has hit a visit cap, a day cap, or a dollar maximum for mental health benefits. This is a textbook quantitative treatment limitation. The parity question: does the plan apply a comparable cap to analogous medical/surgical outpatient services? If a plan covers unlimited physical therapy visits but caps psychotherapy at 30 sessions per year, that's a per-se parity violation under 29 CFR § 2590.712(c). The fix is rarely in dispute once the violation is documented.

CO-167 — Diagnosis Not Covered

The plan is excluding a specific diagnosis from coverage. In behavioral health, this often surfaces as exclusions for adjustment disorder, V-codes, gender dysphoria, or substance use diagnoses. Selectively excluding mental health diagnoses while covering analogous medical conditions is an NQTL under MHPAEA. The plan must demonstrate, on request, that they apply comparable diagnosis-based exclusions to medical/surgical care — which they almost never can.

CO-197 — Precertification/Authorization Absent

Prior authorization is the single most-litigated NQTL. The parity question is structural: does the plan require prior authorization for comparable outpatient medical visits? If not — and most plans don't require PA for routine specialist office visits — then requiring it for psychotherapy is a parity violation. The CAA 2021 demand is especially effective here because the plan's prior-authorization methodology is exactly what § 203 requires them to document.

OA-23 — Prior Authorization Required (Other Payer)

The plan is requiring authorization from another payer before they'll adjudicate. In behavioral health, OA-23 frequently overlaps with coordination of benefits problems. If the authorization requirement is structurally stricter for mental health than for medical/surgical coordination scenarios, that's a parity issue. As always, the CAA 2021 demand puts the comparative-analysis burden on the plan.

When state law beats federal

Five states have parity statutes that are meaningfully stronger than federal MHPAEA. If your patient is in one of them and their plan is fully-insured (not self-funded ERISA), state law is often the faster and stronger argument.

• California — The 2024 SB 855 amendments require coverage for medically necessary treatment of mental health and substance use disorders at all levels of care, hold plans to network adequacy requirements specific to mental health, and require out-of-network coverage at in-network rates if no in-network provider is available.
• New York — NY Ins. Law § 3221(l)(5) imposes parity requirements that, in some cases, exceed federal MHPAEA on benefit-design parity for autism, eating disorders, and SUD treatment.
• Massachusetts — M.G.L. c.176G + Bulletin 2008-04 require coverage for a broad range of biologically-based mental health conditions on parity with medical care.
• Illinois — 215 ILCS 5/370c imposes parity requirements on visit limits, cost-sharing, and treatment limitations for mental health and SUD benefits.
• Oregon — ORS 743A.168 imposes parity with explicit coverage mandates for serious mental illnesses and chemical dependency.

For all other states, federal MHPAEA is the floor. Check the per-state appeal guides for prompt-payment windows, insurance commissioner contact, and state-specific overlay rights.

Anatomy of a winning appeal letter

A parity appeal letter has six sections. Each one does a specific job; together they create a record that's hard for a plan to dismiss.

1. Header. Patient ID, claim number, date of service, denied CPT code, and the CARC code being appealed. Plans process appeals through automated systems first; the header data gets you routed correctly.
2. The parity claim, stated plainly. Open with: “This appeal asserts that the denial constitutes a non-quantitative treatment limitation that violates the Mental Health Parity and Addiction Equity Act of 2008 as amended by § 203 of the Consolidated Appropriations Act of 2021.”
3. The CAA 2021 § 203 demand. The sample paragraph above. Use it verbatim or adapt it.
4. Clinical record. The treating clinician's notes establishing medical necessity for the specific service denied. Date-of-service progress notes carry more weight than retrospective summaries.
5. Comparator argument. Identify the analogous medical/surgical service the plan covers without the same restriction. Example: “The plan covers up to 60 outpatient physical therapy visits per year with no prior authorization. Requiring prior authorization for an equivalent number of psychotherapy visits is a non-quantitative treatment limitation more restrictive than the comparable medical/surgical benefit.”
6. Escalation notice. Close with a clear statement that failure to overturn or produce the comparative analysis will result in (a) external review, (b) a state Department of Insurance complaint for fully-insured plans, or (c) a DOL EBSA complaint for ERISA plans. Mention specific deadlines.

What to do when the plan refuses or stalls

About a third of first-level appeals get overturned outright. Of the remainder, most plans either produce a comparative analysis that obviously fails (creating a stronger case for the second level) or simply stall past their statutory deadline. When that happens, you have three parallel escalation paths, and you should pursue all three simultaneously rather than sequentially.

External review through the state IRO process. For most denials based on medical necessity or experimental/investigational status, federal law guarantees access to an independent external review by a clinical reviewer with no relationship to the plan. The IRO's decision is binding. File once the first internal appeal is denied; the second internal appeal is rarely worth the time.

State Department of Insurance complaint. For fully-insured plans, your state DOI has direct enforcement authority. A complaint citing a specific NQTL parity violation and the plan's failure to produce a CAA 2021 comparative analysis often gets a response from the plan within days. Find your state's DOI through the NAIC consumer locator.

DOL EBSA complaint (ERISA plans). For self-funded employer plans, the federal Department of Labor's Employee Benefits Security Administration handles parity complaints. File at askebsa.dol.gov. EBSA does not adjudicate individual cases, but a complaint creates a record and EBSA does pursue patterns of parity violations.

FAQ